title: Anthrax meningoencephalitis secondary to oral infection.
authors.forename: Yusuf
authors.initials: Y
authors.lastname: Yakupogullari
authors.forename: Nimet
authors.initials: N
authors.lastname: Kabakus
authors.forename: Mehtap
authors.initials: M
authors.lastname: Durukan
authors.forename: Ahmet
authors.initials: A
authors.lastname: Kizirgil
authors.forename: Yasemin
authors.initials: Y
authors.lastname: Bulut
authors.forename: Mustafa
authors.initials: M
authors.lastname: Yilmaz
mesh_terms: D000881:Anthrax / Q000150:complications / Q000175:diagnosis*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001408:Bacillus anthracis / Q000302:isolation & purification*; D002648:Child; D005500:Follow-Up Studies; D006403:Hematologic Tests; D006801:Humans; D008297:Male; D008590:Meningoencephalitis / Q000188:drug therapy* / Q000209:etiology* / Q000382:microbiology; D009059:Mouth Diseases / Q000150:complications* / Q000382:microbiology; D018570:Risk Assessment; D012720:Severity of Illness Index; D013129:Spinal Puncture; D016896:Treatment Outcome; D014421:Turkey
chemical_list: D000900:Anti-Bacterial Agents